LIPID METABOLISM IN DIABETICS WITH AND WITHOUT BLOOD PRESSURE INCREASE by Bozadjieva, E. et al.
Е. Bozadjieva, S. Radeva, G. Varbanov, P. Chankova, I . Danev 
L I P I D METABOLISM IN DIABETICS W I T H AND 
WITHOUT BLOOD PRESSURE INCREASE 
It is generally known that in certain aspects, uncontrolled diabetes re­
sembles the state of fasting: the oxidation of fatty acids in the tissues is 
intensified while that of carbohydrates is lowered, the mobilization of free 
fatty acids by the adipose tissue is intensified and, not infrequently, a rise 
of the triglycerides' blood content occurs (3). 
Substantial changes in the lipid metabolism are likewise observed in 
atherosclerosis (1 , 2). 
Diabetes mellitus is characterized by speeded up development of athero­
sclerosis and often, it runs a course associated with increased blood pres­
sure and furthermore, it is a well known fact that a definite interdepen­
dence exists between atherosclerosis and hypertonic disease. 
We set out to find out whether or not increased blood pressure exerts 
influence on the lipid metabolism and on the lipoprotein-lipase activity 
in diabetes mellitus. 
Investigation was performed on a total of 38 patients with diabetes mel­
litus, of which 16 with increase, and 22 —without increase of the blood 
pressure, as well as on 45 patients with hypertonic disease of which 12 (males 
only) in the first, and 33 in the third stage of disease, according to Lang, 
and on 17 practically healthy, normotonic subjects. The age of the diabe­
tics without increase of the blood pressure ranged from 23 to 67 years, or 
49 y. average, in diabetics with blood pressure increase — from 22 to 70 y., 
or 50 y. average, in hypertonic patients, stage I according to Lang — 19 to 
22 y., or 19.5 y. average, in hypertonic patients, stage I I I according to 
Lang — 28 to 61 y., or 49 y. average and the subjects considered as practi­
cally healthy were 20 to 56 y. old, or 36 y. in the average. Al l patients were 
fed on the respective for their particular affection diet. 
The heparin test was performed in the following manner: in the morn­
ing, before meal, 150 mg heparin were administered over a four-hour 
period by drop infusion of 500 ml physiological serum. Just prior to and 
after the infusion, blood sugar, serum lipids and endogenous heparin were 
examined. Blood-sugar determination was made after the method of 
Haggedorn—Jensen, cholesterol — after Ilko, total lipids — after Brag-
don-Bloor, phospholipids — after Svanberg-Swanerholm, beta-lipoprote-
ins — after Burstein, non-esterified fatty acids — after Dancomb, hepa­
rin —- after Pipta and lipoprotein-lipase activity — after Lukasik. 
Material and Methods 
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Results and Discussions 
The results of our studies show that in diabetics with increased blood 
pressure, besides blood sugar level, also the concentrations of cholesterol, 
total lipids, phospholipids, tri-glycerides, beta-lipoproteins and ncn-este-
rified fatty acids are considerably elevated, whilst the content of endcgencus 
heparin is much lower than in healthy persons. No significant difference 
is established in terms of lipoprotein lipase activity (Table 1). Identica 
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dependence is discovered also among diabetics with increased blood pres­
sure (Table 1). The content of serum lipid fractions, endogenous heparin 
and lipoprotein-lipase disclosed no differences whatsoever between the two 
groups of diabetic patients studied (Table 1). 
The comparative study of the content of lipid fractions, endogenous 
heparin and lipoprotein-lipase activity in diabetics without increased blood 
pressure with that in patients with hypertonic disease, first and third stage 
according to Lang, shows that the concentrations of the single lipid frac­
tions and lipoprotein-lipase activity are significantly higher, whilst the 
endogenous heparin content in diabetic patients is substantially reduced 
(Table 2). The same dependence is established in comparison with patients 
suffering from hypertonia (third stage), except for endogenous heparin which 
reveals a substantial decrease in the latter group. Identical dependence is 
established also between the group of diabetics with increased blood pres­
sure and those with hypertension, stage I and I I I (Table 3). The lipolytic 
effect of heparin is approximately equally manifested in both groups of 
diabetics (Table 4). 
In general outline, our studies of the lipid metabolism in diabetes fail 
to show any differences in the metabolism of lipids, dependent upon the 
blood sugar level, or, in other words, the increased blood pressure in dia-
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stes is by no means reflected by the lipid fractions, endogenous heparin 
and lipoprotein-lipase activity, while variations in the lipid metabolism 
are conditioned by the basic affection exclusively. 
Up to a certain extent, the latter circumstance warrants the assumption 
that increased blood pressure, observed in some patients with diabetes mel­
litus, should by no means be considered as essential hypertension or else 
in this particular case, no combination between diabetes mellitus and hyper­
tonic disease is concerned, but rather diabetes mellitus with concomitant 
hypertension, which, most likely, has its own, different from the hyper­
tonic condition, genesis. 
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The Influence of Heparin upon the Level of Blood Sugar 
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Л И П О И Д Н Ы Й ОБМЕН У ДИАБЕТИКОВ С П О В Ы Ш Е Н Н Ы М 
И С НОРМАЛЬНЫМ КРОВЯНЫМ Д А В Л Е Н И Е М 
Е. Бозаджиева, С. Радева, Г. Варбанов, П. Чанкова, И. Цанев 
Р Е З Ю М Е 
Липопротеин-липазная активность и влияние гепарина на уровень 
сахара крови и липиды сыворотки исследовали у 38 больных сахарной 
болезнью, у 16 из которых кровяное давление было повышено, а у 22 — 
в норме, 45 больных гипертонической болезнью и 17 практически здо­
ровых нормотонических лиц. 
У диабетиков с повышенным и с нормальным кровяным давлением 
по сравнению с больными гипертонической болезнью и нормотониками 
обнаружили более высокое содержание не только сахара крови, но и 
липидных фракций сыворотки, а содержание эндсгеннсго гепарина ока­
залось пониженным. 
В результатах исследования липиднсго обмена при диабете не отме­
чалось различий в обмене липидов в зависимости от уровня кровянсго 
давления. 
